Capital Fund Management (CFM)
ANAB icon

Capital Fund Management (CFM)’s AnaptysBio ANAB Stock Holding History

Capital Fund Management (CFM)’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.64M Buy
+39,142
New +$2.37M 0.01% 1268
2020
Q2 		– Sell
-16,526
Closed -$234K – 1014
2020
Q1 		$234K Buy
+16,526
New +$251K ﹤0.01% 1334
2019
Q1 		– Sell
-8,600
Closed -$549K – 1645
2018
Q4 		$549K Buy
+8,600
New +$640K ﹤0.01% 1335

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Capital Fund Management (CFM)'s ANAB Position: Q2 2026 in Review

Capital Fund Management (CFM) opened a new position in AnaptysBio (ANAB) in Q2 2026: 39,142 shares worth $2.64M. The stake represents 0.01% of the portfolio and ranks #1268 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in ANAB as recently as Q1 2020.

Capital Fund Management (CFM) first reported a position in ANAB in Q4 2018 and has held it in 3 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Capital Fund Management (CFM) held 39,142 shares of AnaptysBio worth $2.64M as of Q2 2026.
  • AnaptysBio was a new Capital Fund Management (CFM) position in Q2 2026.
  • AnaptysBio made up 0.01% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #1268 holding.
  • Capital Fund Management (CFM) first reported a position in AnaptysBio in Q4 2018 and has held it in 3 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.